Spotify to raise US prices in first quarter of next year

Spotify has announced plans to increase its prices in the United States during the first quarter of 2026, as reported by the Financial Times. This decision is part of the company's strategy to enhance profitability amid a competitive streaming market.

Spotify has announced plans to increase its prices in the United States during the first quarter of next year, as reported by the Financial Times. This decision reflects the company's strategy to enhance profitability in a competitive music streaming market.

US hedge funds are currently engaging in short selling, a strategy that anticipates a decline in stock prices, which may indicate a cautious outlook among investors. This trend raises questions about market stability and investor confidence as hedge funds adjust their positions in response to economic signals.

Novo Nordisk's shares have significantly declined following the announcement that its Ozempic medication failed to slow the progression of Alzheimer's disease in two major clinical trials. This outcome represents a substantial setback for one of Europe's largest listed companies, which had high hopes for the drug's efficacy in treating this debilitating condition.

Former President Donald Trump is now facing significant political challenges due to rising prices, which are impacting public sentiment and his approval ratings. As affordability becomes a central issue, Trump must navigate the consequences of economic dissatisfaction among Americans.

Swiss wealth manager Julius Baer has reported a $184 million writedown on its real estate loan book as part of efforts to manage provisions following a series of scandals. This move is seen as a significant setback in the company's turnaround plan aimed at restoring its reputation and financial stability.

Argentina is facing significant economic challenges, including high inflation and mounting debt, prompting discussions for a $20 billion bailout from the US, which has now been shelved in favor of a smaller loan arrangement. This decision reflects the country's ongoing struggle to stabilize its economy and regain investor confidence.

Moderna has become the most shorted stock in the S&P 500 as public interest in Covid-19 vaccinations declines, reflecting a significant downturn for the company since the pandemic's peak. The stock has recently hit a 52-week low of 23.04 USD, indicating a loss of investor confidence.